keyword
https://read.qxmd.com/read/38325793/effects-of-olanzapine-on-hippocampal-ca3-and-the-prefrontal-cortex-local-field-potentials
#21
JOURNAL ARTICLE
Mingwei Gao, Fuqi Wang, Chuanyao Sun, Shuzhuo Zhang, Ruibin Su
Olanzapine is an antipsychotic drug applied in psychiatry to treat psychoses, especially schizophrenia and schizoaffective disorders with similar or better improvement than haloperidol and risperidone in the treatment of depressive and negative symptoms. The effect of olanzapine on neural synchrony remains to be explored. We investigated the effects of olanzapine on gamma oscillations in the CA3 region of the hippocampus and frontal association cortex. Olanzapine reduced carbachol (CCh)-induced gamma oscillation power in CA3 slice and gamma oscillation power in the frontal association cortex in vivo...
February 5, 2024: European Journal of Pharmacology
https://read.qxmd.com/read/38318707/dimensions-and-predictors-of-clinical-and-personal-recovery-in-first-episode-psychoses-results-from-a-cross-sectional-study
#22
JOURNAL ARTICLE
Maria Ferrara, Giulia Zaffarami, Gabriele Simonelli, Ilaria Domenicano, Ludovica Vecchioni, Tommaso Toffanin, Federica Folesani, Spyridon Zotos, Chiara Scrignoli, Raffaella Bertelli, Paola Carozza, Luigi Grassi
INTRODUCTION: First episode psychosis (FEP) services ensure higher recovery rates compared to usual care. The aim of this study was to investigate the different dimensions of recovery and its predictors. METHODS: This cross-sectional study recruited within those admitted to the Ferrara FEP service since 2012 that at the time of analysis were still receiving psychiatric care. At admission, demographic, social and clinical information were collected. In September 2022, patients were assessed with the Health of the Nation Outcome Scale to evaluate clinical/functional recovery, the Recovery Assessment Scale to evaluate personal recovery, and the G12 item of the Positive and Negative Syndrome Scale to evaluate insight...
February 6, 2024: Early Intervention in Psychiatry
https://read.qxmd.com/read/38301343/a-systematic-review-of-performance-based-assessment-studies-on-cognitive-biases-in-schizophrenia-spectrum-psychoses-and-clinical-high-risk-states-a-summary-of-40%C3%A2-years-of-research
#23
REVIEW
Łukasz Gawęda, Joachim Kowalski, Adrianna Aleksandrowicz, Paulina Bagrowska, Małgorzata Dąbkowska, Renata Pionke-Ubych
Cognitive models of psychosis have stimulated empirical studies on cognitive biases involved in schizophrenia spectrum psychoses and their symptoms. This systematic review aimed to summarize the studies on the role of cognitive biases as assessed in different performance-based tasks in schizophrenia spectrum psychoses and clinical high-risk states. We focused on five cognitive biases linked to psychosis, i.e., aberrant salience, attentional biases, source monitoring biases, jumping to conclusions, and bias against disconfirmatory evidence...
January 14, 2024: Clinical Psychology Review
https://read.qxmd.com/read/38253191/the-relationship-between-hot-temperatures-and-hospital-admissions-for-psychosis-in-adults-diagnosed-with-schizophrenia-a-case-crossover-study-in-quebec-canada
#24
JOURNAL ARTICLE
Frédéric Tupinier Martin, Jérémie Boudreault, Céline Campagna, Éric Lavigne, Philippe Gamache, Matthieu Tandonnet, Mélissa Généreux, Simon Trottier, Isabelle Goupil-Sormany
INTRODUCTION: Some studies have found hot temperatures to be associated with exacerbations of schizophrenia, namely psychoses. As climate changes faster in Northern countries, our understanding of the association between temperatures and hospital admissions (HA) for psychosis needs to be deepened. OBJECTIVES: 1) Among adults diagnosed with schizophrenia, measure the relationship between mean temperatures and HAs for psychosis during summers. 2) Determine the influence of individual and ecological characteristics on this relationship...
January 20, 2024: Environmental Research
https://read.qxmd.com/read/38243017/soluble-terminal-complement-complex-blood-levels-are-elevated-in-schizophrenia
#25
JOURNAL ARTICLE
Susa Savukoski, Marco Mannes, Lisa Wohlgemuth, Anke Schultze, Paul C Guest, Gabriela Meyer-Lotz, Henrik Dobrowolny, Borna Relja, Markus Huber-Lang, Johann Steiner
The role of the complement system in schizophrenia (Sz) is inconclusive due to heterogeneity of the disease and study designs. Here, we assessed the levels of complement activation products and functionality of the classical pathway in acutely ill unmedicated Sz patients at baseline and after 6 weeks of treatment versus matched controls. The study included analyses of the terminal complement complex (sTCC) and C5a in plasma from 96 patients and 96 controls by enzyme-linked immunosorbent assay. Sub-group analysis of serum was conducted for measurement of C4 component and activity of the classical pathway (28 and 24 cases per cohort, respectively)...
January 19, 2024: European Archives of Psychiatry and Clinical Neuroscience
https://read.qxmd.com/read/38202213/a-near-fatal-encounter-with-acute-suicidal-behavior-in-anti-n-methyl-d-aspartate-autoimmune-encephalitis
#26
Eunmi Lee, Minjee Kim, Kyu-Hyouck Kyoung, Jin Yong Jun
Anti-N-methyl-D-aspartate receptor encephalitis (anti-NMDARE) is a complex neuropsychiatric syndrome known for its diverse neurological manifestations, often involving psychiatric symptoms and seizures that elevate the risk of suicidal ideation and behavior. We present a case illustrating the potentially lethal nature of anti-NMDARE, wherein an unexpected suicide attempt occurred 10 days after the onset of seizures in a 21-year-old man. Upon arrival at the emergency room, immediate interventions addressed hypovolemic shock, followed by subsequent neurosurgical and orthopedic procedures...
December 29, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/38188526/amylin-receptor-agonism-enhances-the-effects-of-liraglutide-in-protecting-against-the-acute-metabolic-side-effects-of-olanzapine
#27
JOURNAL ARTICLE
Kyle D Medak, Stewart Jeromson, Annalaura Bellucci, Meagan Arbeau, David C Wright
Olanzapine is a second-generation antipsychotic (AP) used in the management of schizophrenia. Although effective at reducing psychoses, APs cause rapid hyperglycemia, insulin resistance, and dyslipidemia, an effect mediated in part by glucagon. We tested if amylin, a hormone that reduces glucagon, or the amylin receptor agonist pramlintide would protect against acute olanzapine-induced impairments in glucose and lipid homeostasis alone or in combination with other glucose-lowering agents such as liraglutide...
January 19, 2024: IScience
https://read.qxmd.com/read/38175611/-antipsychotic-medication-after-a-first-episode-of-psychosis-taper-or-continue
#28
JOURNAL ARTICLE
Lieuwe de Haan, Shiral S Gangadin, Franciska de Beer, Matej Djordjevic, Marieke J H Begemann, Iris E C Sommer
In this paper we discuss the risks and benefits of discontinuing antipsychotic medication within one year after remission of a first episode of psychosis. We start with a fictional case report of a 21-year-old man, who was diagnosed with schizophreniform disorder four months earlier. While symptoms responded well to a daily dose of 10 mg ariprazole, he experienced side effects (tiredness and mild hypersomnia). Three months after symptom remission, he expressed the wish to discontinue his medication. How should psychiatrists respond to his wish? To answer that, we briefly summarize relevant evidence and discuss arguments for the different therapeutic approaches, i...
December 21, 2023: Nederlands Tijdschrift Voor Geneeskunde
https://read.qxmd.com/read/38155489/postpartum-psychosis-a-review-of-risk-factors-clinical-picture-management-prevention-and-psychosocial-determinants
#29
JOURNAL ARTICLE
Justyna Michalczyk, Agata Miłosz, Ewelina Soroka
Postpartum psychosis is rare, but is a serious clinical and social problem. On its own, it is not included in DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) or ICD-10 (International Statistical Classification of Diseases and Related Health Problems) as a disease entity, and current diagnostic criteria equate it with other psychoses. This poses a serious legal problem and makes it difficult to classify. The disorder is caused by a complex combination of biological, environmental, and cultural factors...
December 29, 2023: Medical Science Monitor: International Medical Journal of Experimental and Clinical Research
https://read.qxmd.com/read/38147393/-history-of-the-development-of-domestic-psychiatry-the-period-1940-1980
#30
JOURNAL ARTICLE
N Yu Pyatnitskiy, V G Kaleda
The article briefly presents an analysis of the development of domestic psychiatry (with an emphasis on research in the field of psychopathology and nosology) from the post-war period (the Great Patriotic War) to the era of "perestroika". With the founding of the Institute of Psychiatry of the USSR Academy of Medical Sciences under the leadership of V.A. Gilyarovsky, the study of endogenous diseases was based on a multidisciplinary approach, in which the clinical-psychopathological research method was combined with clinical/biological ones...
2023: Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova
https://read.qxmd.com/read/38128344/identifying-psychosis-subtypes-use-individualized-covariance-structural-differential-networks-and-multi-site-clustering
#31
JOURNAL ARTICLE
Yixin Ji, Godfrey Pearlson, Juan Bustillo, Peter Kochunov, Jessica A Turner, Rongtao Jiang, Wei Shao, Xiao Zhang, Zening Fu, Kaicheng Li, Zhaowen Liu, Xijia Xu, Daoqiang Zhang, Shile Qi, Vince D Calhoun
BACKGROUND: Similarities among schizophrenia (SZ), schizoaffective disorder (SAD) and bipolar disorder (BP) including clinical phenotypes, brain alterations and risk genes, make it challenging to perform reliable separation among them. However, previous subtype identification that transcend traditional diagnostic boundaries were based on group-level neuroimaging features, ignoring individual-level inferences. METHODS: 455 psychoses (178 SZs, 134 SADs and 143 BPs), their first-degree relatives (N = 453) and healthy controls (HCs, N = 220) were collected from Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP I) consortium...
December 20, 2023: Schizophrenia Research
https://read.qxmd.com/read/38128335/duration-of-the-psychosis-prodrome-and-its-relationship-to-duration-of-untreated-psychosis-across-all-12-dsm-iv-psychotic-diagnoses-evidence-for-a-trans-diagnostic-process-associated-with-resilience
#32
JOURNAL ARTICLE
Nnamdi Nkire, Anthony Kinsella, Vincent Russell, John L Waddington
While duration of the psychosis prodrome (DPP) attracts attention in relation to the developmental trajectory of psychotic illness and service models, fundamental issues endure in the context of dimensional-spectrum models of psychosis. Among 205 epidemiologically representative subjects in the Cavan-Monaghan First Episode Psychosis Study, DPP was systematically quantified and compared, for the first time, across all 12 DSM-IV psychotic diagnoses. DPP was also compared with duration of untreated psychosis (DUP) and each was then analysed in relation to premorbid features across three age ranges: <12, 12-15 and 16-18 years...
December 20, 2023: European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology
https://read.qxmd.com/read/38127699/-juvenile-depression-as-at-risk-state-for-psychotic-disorders
#33
JOURNAL ARTICLE
V G Kaleda, M A Omelchenko, V V Migalina
OBJECTIVE: To establish the risk of psychotic disorders in juvenile depression and to study the role of negative symptoms in its formation. MATERIAL AND METHODS: Seventy-four in-patients (19.6±2.3 years old), who were hospitalized for the first time in the clinic for a depressive episode, were examined. Psychometric scales HDRS, SOPS, SANS were used. The risk of manifestation of psychotic disorders was established in the presence of attenuated positive symptoms (APS) with values of at least one of the points P1, P2, P3 and P4 of the corresponding SOPS subscale more or equal to 3...
2023: Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova
https://read.qxmd.com/read/38103060/presentation-of-the-obsolete-drug-reserpine-in-three-german-language-pharmacology-textbooks
#34
JOURNAL ARTICLE
Nikolas Misera, Roland Seifert
For several decades, reserpine was used to treat hypertension and, to a limited extent, psychoses. Over time, however, the indication became more and more restricted to the point of obsolescence. This study examines the extent to which textbooks are up to date in their content and oriented towards therapeutic guidelines, using the obsolete drug reserpine as a paradigm. Three German pharmacology textbook series were examined for the coverage of reserpine from 1964-2023: Allgemeine und Spezielle Pharmakologie und Toxikologie (Aktories), Allgemeine und Spezielle Pharmakologie und Toxikologie (Karow) and Pharmakologie und Toxikologie (Lüllmann)...
December 16, 2023: Naunyn-Schmiedeberg's Archives of Pharmacology
https://read.qxmd.com/read/38097401/external-validation-of-the-five-domains-of-negative-symptoms-focus-on-cognition-functional-capacity-and-real-word-functioning
#35
JOURNAL ARTICLE
Giulia M Giordano, Francesco Sanmarchi, Armida Mucci, Paola Rucci, Francesco Brando, Edoardo Caporusso, Luigi Giuliani, Antonio Melillo, Pasquale Pezzella, Paola Bucci, Paola Rocca, Alessandro Rossi, Alessandro Bertolino, Rodolfo Rossi, Giulio Pergola, Silvana Galderisi, Mario Maj
No abstract text is available yet for this article.
December 15, 2023: European Psychiatry: the Journal of the Association of European Psychiatrists
https://read.qxmd.com/read/38088038/symptomatic-and-functional-outcomes-among-individuals-at-high-risk-for-psychosis-participating-in-step-based-care
#36
JOURNAL ARTICLE
Sarah A Hamilton, Heather M Wastler, Aubrey M Moe, Henry R Cowan, Nancy B Lundin, Hossam H Guirgis, Craig J Parris, Walter H Stearns, Margaret E Manges, Anne C Holmes, Alexandra M Blouin, Nicholas J K Breitborde
Validated, multicomponent treatments designed to address symptoms and functioning of individuals at clinical high risk for psychosis are currently lacking. The authors report findings of a study with such individuals participating in step-based care-a program designed to provide low-intensity, non-psychosis-specific interventions and advancement to higher-intensity, psychosis-specific interventions only if an individual is not meeting criteria for a clinical response. Among individuals with symptomatic or functional concerns at enrollment, 67% met criteria for a symptomatic response (median time to response=11...
December 13, 2023: Psychiatric Services: a Journal of the American Psychiatric Association
https://read.qxmd.com/read/38055146/-interaction-of-somatic-findings-and-psychiatric-symptoms-in-covid-19-a%C3%A2-scoping-review
#37
REVIEW
Hans Rittmannsberger, Martin Barth, Bernd Lamprecht, Peter Malik, Kurosch Yazdi-Zorn
An infection with SARS-CoV‑2 can affect the central nervous system, leading to neurological as well as psychiatric symptoms. In this respect, mechanisms of inflammation seem to be of much greater importance than the virus itself. This paper deals with the possible contributions of organic changes to psychiatric symptomatology and deals especially with delirium, cognitive symptoms, depression, anxiety, posttraumatic stress disorder and psychosis. Processes of neuroinflammation with infection of capillary endothelial cells and activation of microglia and astrocytes releasing high amounts of cytokines seem to be of key importance in all kinds of disturbances...
December 6, 2023: Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation
https://read.qxmd.com/read/38047377/polygenic-risk-for-schizophrenia-predicting-social-trajectories-in-a-general-population-sample
#38
JOURNAL ARTICLE
Aino Saarinen, Jarmo Hietala, Leo-Pekka Lyytikäinen, Binisha Hamal Mishra, Elina Sormunen, Veikka Lavonius, Mika Kähönen, Olli Raitakari, Terho Lehtimäki, Liisa Keltikangas-Järvinen
BACKGROUND: We investigated (a) whether polygenic risk for schizophrenia predicts different trajectories of social development among those who have not developed psychoses and (b) whether possible associations are PRSSCZ -specific or evident also for any polygenic risk for mental disorders, e.g. for major depression. METHODS: Participants came from the population-based Young Finns Study ( n = 2377). We calculated a polygenic risk score for schizophrenia (PRSSCZ ) and for major depression (PRSDEP )...
December 4, 2023: Psychological Medicine
https://read.qxmd.com/read/38039651/20-year-trajectories-of-six-psychopathological-dimensions-in-patients-with-first-episode-psychosis-could-they-be-predicted
#39
JOURNAL ARTICLE
Manuel J Cuesta, Gustavo J Gil-Berrozpe, Ana M Sánchez-Torres, Lucía Moreno-Izco, Elena García de Jalón, Victor Peralta
Patients with first-episode psychoses (FEP) exhibit heterogeneity in clinical manifestations and outcomes. This study investigated the long-term trajectories of six key psychopathological dimensions (reality-distortion, negative, disorganization, catatonia, mania and depression) in patients diagnosed with FEP. A total of 243 patients were followed up for 20 years and the trajectories of the dimensions were analysed using growth mixture modelling. These dimensions showed varied course patterns, ranging from two to five trajectories...
November 25, 2023: Psychiatry Research
https://read.qxmd.com/read/38036032/functional-network-properties-in-schizophrenia-and-bipolar-disorder-assessed-with-high-density-electroencephalography
#40
JOURNAL ARTICLE
Álvaro Díez, Javier Gomez-Pilar, Jesús Poza, Rosa Beño-Ruiz-de-la-Sierra, Inés Fernández-Linsenbarth, María Recio-Barbero, Pablo Núñez, Pedro Holgado-Madera, Vicente Molina
BACKGROUND: The study of the cortical functional network properties in schizophrenia (SZ) may benefit from the use of graph theory parameters applied to high-density electroencephalography (EEG). Connectivity Strength (CS) assesses global synchrony of the network, and Shannon Graph Complexity (SGC) summarizes the network distribution of link weights and allows distinguishing between primary and secondary pathways. Their joint use may help in understanding the underpinnings of the functional network hyperactivation and task-related hypomodulation previously described in psychoses...
November 29, 2023: Progress in Neuro-psychopharmacology & Biological Psychiatry
keyword
keyword
44580
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.